Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating Old and New Paradigms of G1/S Control
Seth M. Rubin, Julien Sage, Jan M. Skotheim
Molecular Cell (2020) Vol. 80, Iss. 2, pp. 183-192
Open Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

Cell cycle control in cancer
Helen K. Matthews, Cosetta Bertoli, Robertus A.M. de Bruin
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 74-88
Open Access | Times Cited: 965
Cell cycle regulation: p53-p21-RB signaling
Kurt Engeland
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 946-960
Open Access | Times Cited: 708
CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities
Erik S. Knudsen, Vishnu Kumarasamy, Ram Nambiar, et al.
Cell Reports (2022) Vol. 38, Iss. 9, pp. 110448-110448
Open Access | Times Cited: 86
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Loretah Chibaya, Jarin T. Snyder, Marcus Ruscetti
Seminars in Cancer Biology (2022) Vol. 86, pp. 827-845
Open Access | Times Cited: 84
β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects
Haoyu Wang, Zhi Wang, Zihui Zhang, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1085-1110
Open Access | Times Cited: 64
Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest
Jason Rodencal, Nathan G. Kim, Andrew He, et al.
Cell chemical biology (2023) Vol. 31, Iss. 2, pp. 234-248.e13
Closed Access | Times Cited: 43
An alternative cell cycle coordinates multiciliated cell differentiation
Semil P. Choksi, Lauren Byrnes, Mia J. Konjikusic, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 214-221
Closed Access | Times Cited: 18
Eukaryotic Cell Size Control and Its Relation to Biosynthesis and Senescence
Shicong Xie, Matthew P. Swaffer, Jan M. Skotheim
Annual Review of Cell and Developmental Biology (2022) Vol. 38, Iss. 1, pp. 291-319
Closed Access | Times Cited: 68
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Zanwen Zuo, Zerong Zhou, Yuzhou Chang, et al.
Genes & Diseases (2022) Vol. 11, Iss. 1, pp. 218-233
Open Access | Times Cited: 48
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6
Alexey V. Sorokin, Preeti Kanikarla Marie, Lea Bitner, et al.
Cancer Research (2022) Vol. 82, Iss. 18, pp. 3335-3344
Open Access | Times Cited: 38
Role of E2F transcription factor in oral cancer: Recent insight and advancements
Amal Kassab, Ishita Gupta, Ala‐Eddin Al Moustafa
Seminars in Cancer Biology (2023) Vol. 92, pp. 28-41
Open Access | Times Cited: 34
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A. Wander, Richard D. Baird, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101103-101103
Open Access | Times Cited: 14
R-loop and diseases: the cell cycle matters
Yuqin Xu, Yue Jiao, Chengbin Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation
Kostas A. Papavassiliou, Amalia A. Sofianidi, Vassiliki A. Gogou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2479-2479
Open Access | Times Cited: 11
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
JACS Au (2024) Vol. 4, Iss. 5, pp. 1911-1927
Open Access | Times Cited: 10
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression
Alexandra Indeglia, Maureen E. Murphy
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 128-138
Open Access | Times Cited: 9
Slower CDK4 and faster CDK2 activation in the cell cycle
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
Structure (2024) Vol. 32, Iss. 8, pp. 1269-1280.e2
Closed Access | Times Cited: 9
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)
Laura Schmitt, Julia Hoppe, Pablo Cea-Medina, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
Kenneth J. Pienta, Emma U. Hammarlund, Robert H. Austin, et al.
Seminars in Cancer Biology (2020) Vol. 81, pp. 145-159
Open Access | Times Cited: 65
Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
Carlos M. González-Casimiro, Beatriz Merino, Elena Casanueva-Álvarez, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 86-86
Open Access | Times Cited: 55
The NUCKS1-SKP2-p21/p27 axis controls S phase entry
Samuel Hume, Cláudia P. Grou, Pauline Lascaux, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis
Laura Solé, Teresa Lobo‐Jarne, Daniel Álvarez‐Villanueva, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
Siyao Deng, Tijana Vlatkovic, Moying Li, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4874-4874
Open Access | Times Cited: 32
Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy
Agnieszka K. Witkiewicz, Vishnu Kumarasamy, Ioannis Sanidas, et al.
Trends in cancer (2022) Vol. 8, Iss. 9, pp. 711-725
Open Access | Times Cited: 30
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
J. Koch, Sebastian Johannes Schober, Sruthi V. Hindupur, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top